HomeNews

News

Novartis’ GanLum Shows Breakthrough Phase 3 Success, Poised to Become First New Malaria Therapy in 25 Years

Ganaplacide lumefantrine combination delivers cure rates above WHO standards, offering new hope against growing artemisinin resistance. London, 13 November 2025 – A major step forward...

Zydus Lifesciences Delivers Strong Q2 FY26 Results with Broad-Based Growth Across Key Markets

Robust revenue expansion, higher profitability, strategic acquisitions, and new product launches position Zydus for a strong year ahead. Sheridan, WY, 13 November 2025 – Zydus...

Implementing a New Framework for Clinical Trials to Accelerate Their Digital Transformation

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, has officially...

Making an Important Proportion of Funds Available to Accelerate Innovation in Regenerative Medicine

The Maryland Stem Cell Research Commission has officially awarded $4,707,142 in grant funding to accelerate the development of innovative stem cell–based therapies. According to certain...

Breaking and Resetting Every Single Standard Associated with Cell and Gene Therapy Manufacturing

EQUASHIELD®, a global leader in healthcare innovation, has officially announced the launch of CellSHIELD®, which happens to be a groundbreaking device, geared towards transforming...

Hot Topics